Greipp PR - Search Results

1

Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?

Greipp PR, Trendle MC, Leong T, Oken MM, Kay NE, Van Ness B, Kyle RA. Greipp PR, et al. Leuk Lymphoma. 1999 Sep;35(1-2):83-9. doi: 10.3109/10428199909145707. Leuk Lymphoma. 1999. PMID: 10512165 Clinical Trial.

2

Detection of hypodiploidy using multi-parameter flow cytometric analysis: a prognostic indicator in multiple myeloma.

Morgan RJ Jr, Gonchoroff NJ, Katzmann JA, Witzig TE, Kyle RA, Greipp PR. Morgan RJ Jr, et al. Among authors: greipp pr. Am J Hematol. 1989 Apr;30(4):195-200. doi: 10.1002/ajh.2830300402. Am J Hematol. 1989. PMID: 2929579

3

Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma.

Witzig TE, Kyle RA, O'Fallon WM, Greipp PR. Witzig TE, et al. Among authors: greipp pr. Br J Haematol. 1994 Jun;87(2):266-72. doi: 10.1111/j.1365-2141.1994.tb04908.x. Br J Haematol. 1994. PMID: 7947266

4

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?

Witzig TE, Gertz MA, Lust JA, Kyle RA, Greipp PR. Witzig TE, et al. Among authors: greipp pr. Leuk Lymphoma. 1995 Nov;19(5-6):417-22. doi: 10.3109/10428199509112199. Leuk Lymphoma. 1995. PMID: 8590841

5

A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma.

Gertz MA, Garton JP, Greipp PR, Witzig TE, Kyle RA. Gertz MA, et al. Among authors: greipp pr. Leukemia. 1995 Dec;9(12):2115-8. Leukemia. 1995. PMID: 8609725 Clinical Trial.

6

Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years.

Bladé J, Kyle RA, Greipp PR. Bladé J, et al. Among authors: greipp pr. Br J Haematol. 1996 May;93(2):345-51. doi: 10.1046/j.1365-2141.1996.5191061.x. Br J Haematol. 1996. PMID: 8639427 Clinical Trial.

7

Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature.

Bladé J, Kyle RA, Greipp PR. Bladé J, et al. Among authors: greipp pr. Arch Intern Med. 1996 Jul 8;156(13):1463-8. doi: 10.1001/archinte.1996.00440120125014. Arch Intern Med. 1996. PMID: 8678716 Review.

8

Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.

Oken MM, Kyle RA, Greipp PR, Kay NE, Tsiatis A, Gregory SA, Spiegel R J, O'Connell M J. Oken MM, et al. Among authors: greipp pr. Leuk Lymphoma. 1996 Feb;20(5-6):447-52. doi: 10.3109/10428199609052427. Leuk Lymphoma. 1996. PMID: 8833401 Clinical Trial.

9

Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.

Greipp PR, Leong T, Bennett JM, Gaillard JP, Klein B, Stewart JA, Oken MM, Kay NE, Van Ness B, Kyle RA. Greipp PR, et al. Blood. 1998 Apr 1;91(7):2501-7. Blood. 1998. PMID: 9516151 Free article. Clinical Trial.

10

Prognostic significance of the S-phase fraction of light-chain-restricted cytoplasmic immunoglobulin (cIg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486.

Trendle MC, Leong T, Kyle RA, Katzmann JA, Oken MM, Kay NE, Van Ness BG, Greipp PR. Trendle MC, et al. Among authors: greipp pr. Am J Hematol. 1999 Aug;61(4):232-7. doi: 10.1002/(sici)1096-8652(199908)61:4<232::aid-ajh2>3.0.co;2-t. Am J Hematol. 1999. PMID: 10440908 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters